Company profile
Shanrong Biotechnology Corp.
OTC: SRBT · Financial Services · Shell Companies
#878 of 1,012 Financial Services companies by revenue
EA Score
——FH —DQ —GM —SS 21
v0.1 · 5/100 weight · pillars only
↑ disclosure history, listing tenure · ↓ Piotroski F, balance-sheet leverage
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$23.5k
Employees
3
as of 2026-08-31
Market cap
$100.0k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02024
Net income-$23.5k-$23.5k2024
Operating income-$23.5k-$23.5k2024
Total assets$1.9k$1.9k2023
Liabilities$662.2k$662.2k2023
Equity-$660.3k-$660.3k2023
Revenue trend
FY2014 – FY2024 · USD
FY14
FY15
FY16
FY17
FY18
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Shanrong Biotechnology Corp.’s revenue?
Shanrong Biotechnology Corp. booked $0 in FY2024 revenue — among the slowest-growing Financial Services companies we track, at a -Infinity% net margin.
Peers · Financial Services
Atlas Resources International, Inc.——Eastern Goldfields, Inc.——Safetek International, Inc.——Solar Gold Ltd.——Royal Standard Minerals Inc.——Safeplus International Holdings Limited——Neighbors
Los Angeles →Key facts
CEOColonel Timothy D. Ringgold
SectorFinancial Services
IndustryShell Companies
HeadquartersBeverly Hills, CA
ExchangeOTC: SRBT
Employees3
IPO date2018-02-09
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.